Literature DB >> 15510187

The effect of overactive bladder syndrome on the sexual quality of life in Korean young and middle aged women.

Y H Kim1, J T Seo, H Yoon.   

Abstract

Some reports showed that urinary incontinence (UI) or female lower urinary tract symptoms (LUTS) affect life quality and sexual activity. In clinical practice, it is commonly found that not only the symptoms of UI but also overactive bladder (OAB) syndrome affect daily lifestyle and sexual activity, especially in women in the most active era in their social and personal life. However, there is lack of data proving the effect of OAB syndrome on sexual activity or sexual life quality in sexually active age group. This study aimed at evaluating the effect of OAB syndrome and UI on the sexual activity and on the sexual quality of life (QoL) of Korean women age from 20s to 40s. We investigated 3372 women aged between 20 and 49 y, enrolled via a multicenter internet survey. A structured questionnaire was used to collect data about their LUTS and sexual activities. The prevalence of OAB syndrome and UI in 3372 women was 12.7 and 21.0%, respectively. Mean subject age was 26.4+/-4.8 y and 79.5% of subjects were 20-29 y old. Having OAB syndrome or UI were found to be significant predictors of sexual life problems (OAB syndrome: OR=5.08, 95% CI=3.68-7.01; UI: OR=4.16, 95% CI=3.06-5.67). Sexual activity was significantly reduced in OAB syndrome and UI versus the asymptomatic group (OAB syndrome: OR=4.8, 95% CI=3.14-6.83; UI: OR=3.9, 95% CI=2.81-5.27). This study is the first internet-based study concerning the sexual QoL in UI and OAB syndrome. In this study, OAB syndrome was found to cause a greater deterioration in the sexual QoL than UI. These results suggest that these symptoms have a significant impact upon women's personal and social lives and markedly affect the QoL.

Entities:  

Mesh:

Year:  2005        PMID: 15510187     DOI: 10.1038/sj.ijir.3901270

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  11 in total

1.  Impact of overactive bladder and lower urinary tract symptoms on sexual health in Japanese women.

Authors:  Tomoko Sako; Miyabi Inoue; Toyohiko Watanabe; Ayano Ishii; Teruhiko Yokoyama; Hiromi Kumon
Journal:  Int Urogynecol J       Date:  2010-08-27       Impact factor: 2.894

2.  The effect of overactive bladder treatment with anticholinergics on female sexual function in women: a prospective observational study.

Authors:  Suleyman Sami Cakir; Recep Burak Degirmentepe; Hasan Anil Atalay; Halil Lutfi Canat; Sait Ozbir; Mehmet Gokhan Culha; Emre Can Polat; Alper Otunctemur
Journal:  Int Urol Nephrol       Date:  2018-11-17       Impact factor: 2.370

Review 3.  Urinary disorders and female sexual function.

Authors:  Jaclyn Chen; Genevieve Sweet; Alan Shindel
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

4.  Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women.

Authors:  Rebecca Rogers; Gloria Bachmann; Zhanna Jumadilova; Franklin Sun; Jon D Morrow; Zhonghong Guan; Tamara Bavendam
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-08-07

5.  Coital urinary incontinence: impact on quality of life as measured by the King's Health Questionnaire.

Authors:  Montserrat Espuña Pons; Montserrat Puig Clota
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-11-01

Review 6.  Stress urinary incontinence and LUTS in women--effects on sexual function.

Authors:  Brigitte Fatton; Renaud de Tayrac; Pierre Costa
Journal:  Nat Rev Urol       Date:  2014-09-09       Impact factor: 14.432

7.  Effects of overactive bladder syndrome on female sexual function.

Authors:  Xiao-Dan Lin; Ning Lin; Zhi-Bin Ke; Ning Xu; Ping Jiang; Hong Li
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

8.  Effect of improvement in lower urinary tract symptoms on sexual function in men: tamsulosin monotherapy vs. combination therapy of tamsulosin and solifenacin.

Authors:  Kyungtae Ko; Dae Yul Yang; Won Ki Lee; Sae Woong Kim; Du Geon Moon; Ki Hak Moon; Nam Cheol Park; Jong Kwan Park; Hwan Cheol Son; Sung Won Lee; Jae Seog Hyun; Kwangsung Park
Journal:  Korean J Urol       Date:  2014-09-05

9.  The effect of extended release tolterodine used for overactive bladder treatment on female sexual function.

Authors:  Athanasios Zachariou; Maria Filiponi
Journal:  Int Braz J Urol       Date:  2017 Jul-Aug       Impact factor: 1.541

10.  The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study.

Authors:  A Zachariou; C Mamoulakis; M Filiponi; F Dimitriadis; J Giannakis; S Skouros; P Tsounapi; A Takenaka; N Sofikitis
Journal:  BMC Urol       Date:  2018-06-25       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.